z-logo
Premium
Interventional bronchoscopy for chronic obstructive pulmonary disease: more than a pipe dream
Author(s) -
Carew Alan M,
Williamson Jonathan P,
Farah Claude S,
Saghaie Tajalli,
Phillips Martin,
Ing Alvin
Publication year - 2021
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja2.51218
Subject(s) - copd , medicine , intensive care medicine , quality of life (healthcare) , psychological intervention , pulmonary disease , lung function , bronchoscopy , lung , surgery , nursing
Summary Endoscopic lung volume reduction (ELVR) is recognised in both national and international expert guidelines as one of the few additive treatments to benefit patients with advanced chronic obstructive pulmonary disease (COPD) who are otherwise receiving optimal medical and supportive care. Despite these recommendations and a growing evidence base, these procedures are not widely offered across Australia and New Zealand, and general practitioner and physician awareness of this therapy can be improved. ELVR aims to mitigate the impact of hyperinflation and gas trapping on dyspnoea and exercise intolerance in COPD. Effective ELVR is of proven benefit in improving symptoms, quality of life, lung function and survival. Several endoscopic techniques to achieve ELVR have been developed, with endobronchial valve placement to collapse a single lobe being the most widely studied and commonly practised. This review describes the physiological rationale underpinning lung volume reduction, highlights the challenges of patient selection, and provides an overview of the evidence for current and investigational endoscopic interventions for COPD.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here